Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Hackensack Meridian Health
University College, London
University of Chicago
M.D. Anderson Cancer Center
University of Chicago
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
University of Wisconsin, Madison
Massachusetts General Hospital
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
University of Washington
City of Hope Medical Center
City of Hope Medical Center
Institut Bergonié
Universität des Saarlandes
Insel Gruppe AG, University Hospital Bern
University of Washington
International Extranodal Lymphoma Study Group (IELSG)
Northwestern University
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
University of Miami
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Hackensack Meridian Health
M.D. Anderson Cancer Center
Columbia University
Masonic Cancer Center, University of Minnesota
Academic and Community Cancer Research United
City of Hope Medical Center
Case Comprehensive Cancer Center
IRCCS San Raffaele
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Stanford University
City of Hope Medical Center
University of Nebraska
University of Nebraska
University of Nebraska
University of Nebraska
University of Nebraska
University of Nebraska